| Identification | Back Directory | [Name]
3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide | [CAS]
1610420-28-4 | [Synonyms]
(Rac)-MRI-1867
(Rac)-Zevaquenabant
3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide
1H-Pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-4,5-dihydro-N'-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]- | [Molecular Formula]
C25H21ClF3N5O2S | [MOL File]
1610420-28-4.mol | [Molecular Weight]
547.98 |
| Chemical Properties | Back Directory | [Boiling point ]
621.2±65.0 °C(Predicted) | [density ]
1.42±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
6.70±0.60(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide, can be used in synthesis of novel dual-target compounds with antagonist/inverse agonist activity at cannabinoid receptor type 1 (CB1R) and inhibitory effect on inducible nitric oxide synthase (iNOS). |
|
|